Tech Company Financing Transactions
Bioniz Therapeutics Funding Round
Private investors participated in a $8 million funding round for Bioniz Therapeutics. This venture round was announced on 1/28/2019.
Transaction Overview
Company Name
Announced On
1/28/2019
Transaction Type
Debt
Amount
$8,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 9 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5 Mason St. 275
Irvine, CA 92618
USA
Irvine, CA 92618
USA
Phone
Website
Email Address
Overview
Bioniz is a biopharmaceutical company leading the discovery and development of first-in-class multi-cytokine inhibitory peptide therapeutics to address immuno-inflammatory diseases and cancer, with an initial focus on orphan diseases that have an immune component.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nazli Azimi
Chief Operating Officer
Fredrik Wiklund
Co-Founder
Yutaka Tagaya
Browse more venture capital transactions:
Prev: 1/28/2019: Fernish venture capital transaction
Next: 1/28/2019: Cargo Chief venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs